Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward. (Q48489442)

12 February 2018

title

Blockade of 5-HT2a receptors reduces haloperidol-induced attenuation of reward. (English)

1 reference

12 February 2018

author

Shitij Kapur

series ordinal

2

1 reference

12 February 2018

Pierre-Paul Rompré

series ordinal

3

object named as

Pierre-Paul Rompré

1 reference

12 February 2018

author name string

Faïza Benaliouad

series ordinal

1

1 reference

12 February 2018

language of work or name

English

0 references

publication date

14 June 2006

1 reference

12 February 2018

published in

Neuropsychopharmacology

1 reference

12 February 2018

volume

32

1 reference

12 February 2018

issue

3

1 reference

12 February 2018

page(s)

551-561

1 reference

12 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301136

exact match

0 references

cites work

Second-generation antipsychotics: looking beyond efficacy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Application of in vivo electrochemistry to the measurement of changes in dopamine release during intracranial self-stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Effect of pimozide on self-stimulation threshold under a continuous and fixed-interval schedule of reinforcement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Effects of nucleus accumbens amphetamine on lateral hypothalamic brain stimulation reward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Ketamine blocks the plasticity associated with prefrontal cortex self-stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Subjective experience and dopamine D2 receptor occupancy in patients treated with antipsychotics: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Prefrontal cortex infusions of SCH 23390 cause immediate and delayed effects on ventral tegmental area stimulation reward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Affinity for the dopamine D2 receptor predicts neuroleptic potency in blocking the reinforcing effect of MFB stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Psychosis and drug dependence: results from a national survey of prisoners

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

The influence of amphetamine on preference for lateral hypothalamic versus prefrontal cortex or ventral tegmental area self-stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Half a century of antipsychotics and still a central role for dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

5-HT2A receptor stimulation by DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

5-HT(2A) receptor antagonism potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and inhibits that in the nucleus accumbens in a dose-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

The role of serotonin in antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

The curve-shift paradigm in self-stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Neurotransmitters, pathways and circuits as the neural substrates of self-stimulation of the prefrontal cortex: facts and speculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Reversal of amphetamine-induced behaviours by MDL 100,907, a selective 5-HT2A antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Differential effect of self-stimulation on dopamine release and metabolism in the rat medial frontal cortex, nucleus accumbens and striatum studied by in vivo microdialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Intracranial self-stimulation increases differentially in vivo hydroxylation of tyrosine but similarly in vivo hydroxylation of tryptophan in rat medial prefrontal cortex, nucleus accumbens and striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Increased dopamine and serotonin metabolism in rat nucleus accumbens produced by intracranial self-stimulation of medial forebrain bundle as measured by in vivo microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

The involvement of dopamine D2 receptors, but not D3 or D4 receptors, in the rewarding effect of brain stimulation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

The role of 5-HT(2A) receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

5-HT2 receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Rostral-caudal differences in effects of nucleus accumbens amphetamine on VTA ICSS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Elevated dopa decarboxylase activity in living brain of patients with psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Multiple reward systems and the prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Psychostimulant-like effect of central microinjection of neurotensin on brain stimulation reward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

The substrates for self-stimulation of the lateral hypothalamus and medial prefrontal cortex: a comparison of strength-duration characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Dopamine receptors and the dopamine hypothesis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Dopamine receptor sub-types involvement in nucleus accumbens and ventral tegmentum but not in medial prefrontal cortex: on self-stimulation of lateral hypothalamus and ventral mesencephalon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Regional neuroleptic microinjections indicate a role for nucleus accumbens in lateral hypothalamic self-stimulation reward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

The medial prefrontal cortex as a part of the brain reward system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Neuroleptic dysphoria: towards a new synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Enhancement of antipsychoticlike properties of raclopride in rats using the selective serotonin2A receptor antagonist MDL 100,907.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Brain dopamine and reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

7 January 2021

Fos expression following self-stimulation of the medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

7 January 2021

Behavioral evidence of depolarization block of dopamine neurons after chronic treatment with haloperidol and clozapine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

7 January 2021

Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

7 January 2021

The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

7 January 2021

Evidence for functional interactions between 5-HT1A and 5-HT2A receptors in rat thermoregulatory mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301136

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301136

1 reference

12 February 2018

PubMed ID

16794561

1 reference

12 February 2018